Related Articles
miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer
The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma
Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma
miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2
Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells